Objective To study the timing of presentation and perinatal high-risk factors for necrotizing enterocolitis (NEC) in preterm infants with a gestational age of <33 weeks. Methods A case-control study was conducted in 49 preterm infants with NEC (gestational age <33 weeks) who were admitted to the Neonatal Intensive Care Unit of Beijing Bayi Children's Hospital between October 1, 2010 and December 30, 2012, as well as preterm infants without NEC during the same period. The timing of presentation of NEC was retrospectively analyzed, and the perinatal high-risk factors for NEC were determined by multivariate logistic regression analysis. Results The median age of onset was 17.5 days (range: 3-106 d) in preterm infants with NEC. Sex, being small for gestational age, delivery mode and antenatal corticosteroid therapy were not associated with the development of NEC; low gestational age, low birth weight and neonatal asphyxia increased the risk of NEC, and low gestational age was identified as an independent high-risk factor for the development of NEC. Conclusions Low gestational age is an important risk factor for the development NEC in preterm infants under 33 weeks' gestation, and the median age of onset is 17.5 days.
Key words
Necrotizing enterocolitis /
Risk factor /
Gestational age /
Preterm infant
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Piazza AJ, Stroll BJ. Digestive System Disorders[M]// Kliegman RM, Behrman RE, Jenson HB, et al, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa: Saunders Elsevier, 2007.
[2] Song R, Subbarao GC, Maheshwari A. Haematological abnormalities in neonatal necrotizing enterocolitis[J]. J Matern Fetal Neonatal Med, 2012(Suppl 4): 22-25.
[3] Christensen RD, Gordon PV, Besner GE. Can we cut the incidence of necrotizing enterocolitis in half——today?[J]. Fetal Pediatr Pathol, 2010, 29(4): 185-198.
[4] Miller RJ, Sullivan MC, Hawes K, et al. The effects of perinatal morbidity and environmental factors on health status of preterm children at age 12[J]. J Pediatr Nurs, 2009, 24(2): 101-114.
[5] Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging[J]. Ann Surg, 1978, 187(1): 1-7.
[6] Torrazza RM1, Ukhanova M, Wang X, et al. Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis[J]. PLoS One, 2013, 8(12): e83304.
[7] Thompson AM, Bizzarro MJ. Necrotizing enterocolitis in newborns: pathogenesis, prevention and management[J]. Drugs, 2008, 68(9): 1227-1238.
[8] 李联侨, 吴斌, 高璇璇, 等. 微生态制剂防治新生儿坏死性小肠结肠炎病例对照研究[J]. 中国当代儿科杂志, 2006, 8 (6): 464-466.
[9] 郑继芳. 围产儿窒息并发坏死性小肠结肠炎(NEC)临床探讨[J].中国社区医师, 2002, 18(15): 26-27.
[10] Marin T, Strickland OL. Transfusion-related necrotizing enterocolitis: a conceptual framework[J]. Adv Neonatal Care, 2013, 13(3): 166-174.
[11] Neu J, Walker WA. Necrotizing enterocolitis[J]. N Engl J Med, 2011, 364(3): 255-264.
[12] Yee WH, Soraisham AS, Shah VS, et al. Incidence and timing of presentation of necrotizing enterocolitis in preterm infants[J]. Pediatrics, 2012, 129(2): 298-304.
[13] Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth[J].Cochrane Database Syst Rev. 2006, (3): CD004454.
[14] Romejko-Wolniewicz E, Oleszczuk L, Zareba-Szczudlik J, et al. Dosage regimen of antenatal steroids prior to preterm delivery and effects on maternal and neonatal outcomes[J]. J Matern Fetal Neonatal Med, 2013, 26(3): 237-241.
[15] Bortolin L, Boer M, Christiansen S, et al. Effects of prenatal steroids in the development of necrotizing enterocolitis in Wistar rat neonates[J]. Arch Argent Pediatr, 2011, 109(1): 24-29.
PDF(1402 KB)
